Norian SRS versus functional treatment in redisplaced distal radial fractures: a randomized study in 20 patients.
We compared the use of Norian SRS, an injectable calcium phosphate bone cement, with functional treatment of redisplaced distal radial fractures in a prospective randomized study of 20 patients. The redisplaced fractures were either rereduced and stabilized by Norian SRS, or the displaced position was accepted and was not rereduced. All wrists were immobilized in a short-arm dorsal splint for 1 week, followed by a removable splint for another 3 weeks. The chosen primary effect variable was grip strength at 7 weeks, and this did not differ between the two treatment groups. The clinical results at 6 months in both groups were similar. We conclude that aggressive treatment of redisplaced fractures of the distal radius may be unnecessary in most women aged 50 years or more.
Kopylov
P
P
Department of Orthopedics, Lund University, Lund, Sweden. philippe.kopylov@ort.lu.se
Adalberth
K
K
Jonsson
K
K
Aspenberg
P
P
D000368:Aged; D018786:Bone Substitutes / Q000008:administration & dosage / Q000627:therapeutic use*; D002130:Calcium Phosphates / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D018737:Hand Strength; D006801:Humans; D007103:Immobilization; D008875:Middle Aged; D011446:Prospective Studies; D011885:Radius Fractures / Q000628:therapy*; D016896:Treatment Outcome
D018786:Bone Substitutes; D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous